PECAM1 and glioblastoma: To unambiguously quantify the proportion of tumor vessels expressing FAP in our own tissue samples, we performed immunofluorescence staining for FAP together with the EC marker CD31 on fresh‐frozen glioblastoma tissues from nine patients.